ESC Congress coverages: The interventional cardiology perspective

Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.

Mirvat Alasnag and Pieter C Smits discuss the design of the randomised controlled trial COMPARE-ABSORB and the 5-year results which he presented during the ESC Congress 2023 in Amsterdam.

Ali Nazmi Calik interviews Gregg Stone about the results of the meta-analysis which he presented during the ESC Congress 2023 in Amsterdam. It showed that intravascular imaging-guided PCI (IVUS or OCT) reduces target lesion failure, cardiac death, myocardial infarction, and revascularization compared to angiography-guided PCI.

Ali Nazmi Calik interviews Duk-Woo Park & Do-Yoon Kang regarding the results of the OCTIVUS trial which were presented during the ESC Congress 2023 in Amsterdam.

Key message is that optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding percutaneous coronary intervention (PCI).

Dejan Milasinovic provides his take on the final results of the OCTOBER trial which were presented by Lene Nyhus Andreasen during the ESC 2023 congress in Amsterdam.

Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...

Aaysha Cader interviews Barbara Elisabeth Stahli on the study design and results that she presented during the ESC Congress 2023 in Amsterdam. 

Immediate multivessel PCI was non-inferior to staged multivessel PCI for reducing death and ischemic events in patients with STEMI and multivessel coronary artery disease.

Aaysha Cader interviews Masahiro Natsuaki about the design and results of the STOPDAPT-3 trial which he presented during the ESC Congress 2023 in Amsterdam.

Prasugrel monotherapy after PCI with drug-eluting stents was not superior to dual-antiplatelet therapy (DAPT) for major bleeding but was non-inferior for cardiovascular events...

Panos Xaplanteris & Leonidas Koliastasis provide their take on the final results of the ECLS-SHOCK (Extracorporeal Life Support in Infarct-Related Cardiogenic Shock) which were presented by Holger Thiele during the ESC 2023 congress in Amsterdam.

Luis Ortega-Paz interviews Simone Biscaglia and Gianluca Campo about the FIRE trial.
Results showed elderly patients presenting with either STEMI or NSTEMI benefit from complete revascularization, reducing cardiovascular events risk at 1 year compared to culprit lesion-only PCI.

Published simultaneously in the New England Journal of Medicine